Isthmus Partners LLC Reduces Holdings in DocGo Inc. (NASDAQ:DCGO)

Isthmus Partners LLC trimmed its holdings in DocGo Inc. (NASDAQ:DCGO) by 2.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 623,928 shares of the company’s stock after selling 14,100 shares during the quarter. Isthmus Partners LLC owned approximately 0.61% of DocGo worth $2,645,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. JPMorgan Chase & Co. lifted its stake in shares of DocGo by 151.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company’s stock worth $365,000 after acquiring an additional 66,097 shares during the period. Matrix Asset Advisors Inc. NY acquired a new stake in shares of DocGo in the 4th quarter worth approximately $424,000. Harbor Capital Advisors Inc. grew its holdings in DocGo by 37.5% in the fourth quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company’s stock valued at $5,647,000 after purchasing an additional 363,391 shares during the last quarter. WCM Investment Management LLC increased its holdings in DocGo by 64.2% during the 4th quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company’s stock valued at $18,637,000 after acquiring an additional 1,687,100 shares in the last quarter. Finally, Barclays PLC increased its stake in shares of DocGo by 279.7% during the 3rd quarter. Barclays PLC now owns 134,923 shares of the company’s stock worth $447,000 after purchasing an additional 99,387 shares in the last quarter. 56.44% of the stock is owned by hedge funds and other institutional investors.

DocGo Trading Up 3.4 %

DCGO opened at $3.03 on Monday. The business’s 50 day moving average is $4.45 and its 200-day moving average is $4.00. The stock has a market cap of $309.21 million, a PE ratio of 10.82, a price-to-earnings-growth ratio of 14.16 and a beta of 1.08. DocGo Inc. has a twelve month low of $2.75 and a twelve month high of $5.68.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the stock. Stifel Nicolaus cut their price objective on shares of DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a research report on Friday, February 28th. Needham & Company LLC dropped their price objective on shares of DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a research note on Friday, February 28th. Finally, Deutsche Bank Aktiengesellschaft lowered DocGo from a “buy” rating to a “hold” rating and cut their target price for the stock from $5.00 to $2.85 in a research report on Friday, February 28th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $4.89.

Insiders Place Their Bets

In other news, General Counsel Ely D. Tendler sold 23,088 shares of DocGo stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $4.44, for a total value of $102,510.72. Following the transaction, the general counsel now owns 175,645 shares of the company’s stock, valued at $779,863.80. The trade was a 11.62 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 2.70% of the stock is currently owned by insiders.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.